ClinicalTrials.Veeva

Menu

Improvement of Facial Nerve Monitoring in Parotid Surgery by Sugammadex

K

Kaohsiung Medical University

Status

Completed

Conditions

Injury to Nerve During Surgery

Treatments

Drug: sugammadex (Bridion)

Study type

Observational

Funder types

Other

Identifiers

NCT02314234
KMUH-IRB-20140248

Details and patient eligibility

About

To investigate the effectiveness of rapid reversal of rocuronium-induced neuromuscular block by sugammadex during IONM of facial nerve during parotid surgery

Full description

Intraoperative neuromonitoring (IONM) of facial nerve has been applied in identifying and preserving facial nerve during parotid surgery. In this setting, even a single dose of nondepolarizing muscle relaxant may lead to delayed and weakened electromyography (EMG) signal in facial nerve monitoring during parotid surgery. The aim of this study was to investigate the effectiveness of rapid reversal of rocuronium-induced neuromuscular block by sugammadex during IONM of facial nerve during parotid surgery

Enrollment

50 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • undergoing parotid surgery

Exclusion criteria

  • facial nerve injury, renal failure, liver cirrhosis, neuromuscular disease

Trial design

50 participants in 2 patient groups

Control group
Description:
did not receive muscle relaxant during anesthesia
Sugammadex group
Description:
received single dose of rocuronium for anesthesia and sugammadex at skin incision
Treatment:
Drug: sugammadex (Bridion)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems